PubMed:33115285
Annnotations
Zierdiyeerkenaili_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 38-49 | CI | denotes | Secukinumab |
| T19 | 465-474 | DP | denotes | psoriasis |
| T20 | 126-135 | DP | denotes | Psoriasis |
| T21 | 835-844 | DP | denotes | Psoriasis |
| T22 | 221-230 | DP | denotes | psoriasis |
| T23 | 391-400 | DP | denotes | psoriasis |
| T24 | 549-558 | DP | denotes | psoriasis |
| T25 | 1087-1096 | DP | denotes | psoriasis |
| T26 | 1266-1275 | DP | denotes | psoriasis |
| T8 | 24-34 | CI | denotes | Ixekizumab |
| T9 | 262-272 | CI | denotes | Ixekizumab |
| T27 | 335-345 | CI | denotes | ixekizumab |
| T28 | 648-658 | CI | denotes | ixekizumab |
| T29 | 1023-1033 | CI | denotes | ixekizumab |
| T30 | 350-361 | CI | denotes | secukinumab |
| T31 | 704-715 | CI | denotes | secukinumab |
| T32 | 1045-1056 | CI | denotes | secukinumab |
yaoziqian_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 24-34 | CI | denotes | Ixekizumab |
| T10 | 704-715 | CI | denotes | secukinumab |
| T11 | 1023-1033 | CI | denotes | ixekizumab |
| T12 | 1045-1056 | CI | denotes | secukinumab |
| T15 | 549-558 | DP | denotes | psoriasis |
| T18 | 465-474 | DP | denotes | psoriasis |
| T19 | 126-135 | DP | denotes | Psoriasis |
| T2 | 38-49 | CI | denotes | Secukinumab |
| T20 | 835-844 | DP | denotes | Psoriasis |
| T21 | 221-230 | DP | denotes | psoriasis |
| T22 | 391-400 | DP | denotes | psoriasis |
| T23 | 1087-1096 | DP | denotes | psoriasis |
| T24 | 1266-1275 | DP | denotes | psoriasis |
| T5 | 262-272 | CI | denotes | Ixekizumab |
| T6 | 335-345 | CI | denotes | ixekizumab |
| T7 | 350-361 | CI | denotes | secukinumab |
| T9 | 648-658 | CI | denotes | ixekizumab |